Peter S. Conti
Direktor/Vorstandsmitglied bei FluoroPharma, Inc.
Profil
Peter S.
Conti is currently a Director at FluoroPharma, Inc. and AZTherapies, Inc. He is also a Director at NanoTomer, Inc. and a Professor at the University of Southern California.
Previously, he was the Director of Molecular Imaging Corp.
from 2002 to 2008.
He also served as an Independent Director at FluoroPharma Medical, Inc. and as the President of the Society of Nuclear Medicine & Molecular Imaging.
Conti earned a doctorate degree from Cornell University.
Aktive Positionen von Peter S. Conti
| Unternehmen | Position | Beginn |
|---|---|---|
FluoroPharma, Inc.
 FluoroPharma, Inc. Medical SpecialtiesHealth Technology FluoroPharma, Inc. manufactures diagnostic imaging products. It engages in the discovery, development and commercialization of proprietary diagnostic imaging products. The company was founded by David R. Elmaleh in 2003 and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | - |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | 01.01.1991 |
| USC Pet Imaging Science Center | Direktor/Vorstandsmitglied | 01.01.1991 |
AZTherapies, Inc.
 AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | - |
NanoTomer, Inc.
 NanoTomer, Inc. Miscellaneous Commercial ServicesCommercial Services NanoTomer, Inc. provides bio technology services. The company is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Peter S. Conti
| Unternehmen | Position | Ende |
|---|---|---|
Molecular Imaging Corp.
 Molecular Imaging Corp. Medical/Nursing ServicesHealth Services Molecular Imaging Corp. provides molecular imaging services to the healthcare industry. It is a diagnostic imaging procedure used to diagnose, monitor and assess disease severity for many cancers, cardiovascular disease and neurological disorders. The firm's procedures display metabolic and functional characteristics of disease, which typically are the first indications of disease. It also provides a newer combined MI/CT system. The company was founded by Paul J. Crowe on August 21, 1985 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | 04.12.2008 |
| FLUOROPHARMA MEDICAL, INC. | Direktor/Vorstandsmitglied | - |
Society of Nuclear Medicine & Molecular Imaging
 Society of Nuclear Medicine & Molecular Imaging Miscellaneous Commercial ServicesCommercial Services The Society of Nuclear Medicine & Molecular Imaging is a non-profit organization that promotes the science, technology, and practical application of nuclear medicine and molecular imaging. The private company is based in Reston, VA. | Präsident | - |
Ausbildung von Peter S. Conti
| Cornell University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FLUOROPHARMA MEDICAL, INC. | Commercial Services |
| Private Unternehmen | 6 |
|---|---|
Molecular Imaging Corp.
Molecular Imaging Corp. Medical/Nursing ServicesHealth Services Molecular Imaging Corp. provides molecular imaging services to the healthcare industry. It is a diagnostic imaging procedure used to diagnose, monitor and assess disease severity for many cancers, cardiovascular disease and neurological disorders. The firm's procedures display metabolic and functional characteristics of disease, which typically are the first indications of disease. It also provides a newer combined MI/CT system. The company was founded by Paul J. Crowe on August 21, 1985 and is headquartered in San Diego, CA. | Health Services |
FluoroPharma, Inc.
FluoroPharma, Inc. Medical SpecialtiesHealth Technology FluoroPharma, Inc. manufactures diagnostic imaging products. It engages in the discovery, development and commercialization of proprietary diagnostic imaging products. The company was founded by David R. Elmaleh in 2003 and is headquartered in Boston, MA. | Health Technology |
AZTherapies, Inc.
AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA. | Health Technology |
| USC Pet Imaging Science Center | |
Society of Nuclear Medicine & Molecular Imaging
Society of Nuclear Medicine & Molecular Imaging Miscellaneous Commercial ServicesCommercial Services The Society of Nuclear Medicine & Molecular Imaging is a non-profit organization that promotes the science, technology, and practical application of nuclear medicine and molecular imaging. The private company is based in Reston, VA. | Commercial Services |
NanoTomer, Inc.
NanoTomer, Inc. Miscellaneous Commercial ServicesCommercial Services NanoTomer, Inc. provides bio technology services. The company is headquartered in Boston, MA. | Commercial Services |
